Thiolated particles as effective intravesical drug delivery systems for treatment of bladder-related diseases

Nanomedicine

Volumn 8, Issue 1, 2013, Pages 65-75

  Barthelmes, Jan ^a   Dünnhaupt, Sarah ^a   Unterhofer, Sibylle ^a   Perera, Glen ^a   Schlocker, Wolfgang ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

intravesical drug delivery system; microparticle; mucoadhesion; nanoparticle; urinary bladder

Indexed keywords

BIOMATERIAL; CHITOSAN; MICROPARTICLE; NANOPARTICLE; POLYMER; THIOGLYCOLIC ACID; THIOLATED POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER DISEASE; DRUG DELIVERY SYSTEM; FEMALE; INTRAVESICAL DRUG ADMINISTRATION; MUCOADHESION; NONHUMAN; PRIORITY JOURNAL; RAT; SWINE;

EID: 84871581557     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.76     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 60(5), 277-300 (2010
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 61(2), 69-90 (2011
3. Hanno PM, Chapple CR, Cardozo LD. Bladder pain syndrome/interstitial cystitis. A sense of urgency. World J. Urol. 27(6), 717-721 (2009
4. Evans RJ. Intravesical therapy for overactive bladder. Curr. Urol. Rep. 6(6), 429-433 (2005
5. Buyse G, Waldeck K, Verpoorten C, Bjork H, Casaer P, Andersson KE. Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J. Urol. 160(3 Pt 1), 892-896 (1998
6. Guhasarkar S, Banerjee R. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies. J. Control. Release 148(2), 147-159 (2010
7. Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev. Ind. Pharm. 26(9), 913-924 (2000
8. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv. Drug Deliv. Rev. 57(11), 1556-1568 (2005
9. Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin. Biol. Ther. 2(3), 287-298 (2002
10. Kerec Kos M, Bogataj M, Mrhar A. Enhanced permeability of the urinary bladder wall: The role of polymer charge. Pharmazie 64(4), 232-237 (2009
11. Kerec M, Bogataj M, Veranic P, Mrhar A. Permeability of pig urinary bladder wall: The effect of chitosan and the role of calcium. Eur. J. Pharm. Sci. 25(1), 113-121 (2005
12. Leitner VM, Walker GF, Bernkop-Schnürch A. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur. J. Pharm. Biopharm. 56(2), 207-214 (2003
13. Barthelmes J, Perera G, Hombach J, Dünnhaupt S, Bernkop- Schnürch A. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int. J. Pharm. 416(1), 339-345 (2011
14. Chutipongtanate S, Thongboonkerd V. Systematic comparisons of artificial urine formulas for in vitro cellular study. Anal. Biochem. 402(1), 110-112 (2010
15. Greindl M. Oral Drug Delivery: Design and In Vitro/In Vivo Evaluation of Novel Permeation Enhancers and Efflux Inhibitors. University of Innsbruck, Austria, 8-9 (2008
16. Marschütz MK, Bernkop-Schnürch A. Thiolated polymers: Self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur. J. Pharm. Sci. 15(4), 387-394 (2002
17. Brown HH. A study of 2,4,6-trinitrobenzenesulfonic acid for automated amino acid chromatography. Clin. Chem. 14(10), 967-978 (1968
18. Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharm. Res. 16(6), 876-881 (1999
19. Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J. Control. Release 111(1-2), 41-46 (2006
20. Bernkop-Schnürch A, Weithaler A, Albrecht K, Greimel A. Thiomers: Preparation and in vitro evaluation of a mucoadhesive nanoparticulate drug delivery system. Int. J. Pharm. 317(1), 76-81 (2006
21. Greindl M, Bernkop-Schnürch A. Development of a novel method for the preparation of thiolated polyacrylic acid nanoparticles. Pharm. Res. 23(9), 2183-2189 (2006
22. Bogataj M, Mrhar A, Korosec L. Influence of physicochemical and biological parameters on drug release from microspheres adhered on vesical and intestinal mucosa. Int. J. Pharm. 177(2), 211-220 (1999
23. Sakloetsakun D, Hombach JM, Bernkop- Schnürch A. In situ gelling properties of chitosan-thioglycolic acid conjugate in the presence of oxidizing agents. Biomaterials 30(31), 6151-6157 (2009
24. Albrecht K, Zirm EJ, Palmberger TF, Schlocker W, Bernkop-Schnürch A. Preparation of thiomer microparticles and in vitro evaluation of parameters influencing their mucoadhesive properties. Drug Dev. Ind. Pharm. 32(10), 1149-1157 (2006
25. Hassan EE, Gallo JM. A simple rheological method for the in vitro assessment of mucin-polymer bioadhesive bond strength. Pharm. Res. 7(5), 491-495 (1990
26. Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements. Eur. J. Pharm. Sci. 10(4), 251-257 (2000
27. Rossi S, Ferrari F, Bonferoni MC, Caramella C. Characterization of chitosan hydrochloride-mucin rheological interaction: Influence of polymer concentration and polymer:mucin weight ratio. Eur. J. Pharm. Sci. 12(4), 479-485 (2001
28. Ferrari F, Rossi S, Bonferoni MC, Caramella C, Karlsen J. Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride. Farmaco 52(6-7), 493-497 (1997
29. Dhawan S, Singla AK, Sinha VR. Evaluation of mucoadhesive properties of chitosan microspheres prepared by different methods. AAPS PharmSciTech 5(4), e67 (2004
30. St Clair MB, Sowers AL, Davis JA, Rhodes LL. Urinary bladder catheterization of female mice and rats. Contemp. Top. Lab. Anim. Sci. 38(3), 78-79 (1999
31. Lamprecht A, Schafer U, Lehr CM. Size dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm. Res. 18(6), 788-793 (2001
32. Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv. Drug Deliv. Rev. 47(1), 39-54 (2001
33. Ponchel G, Montisci MJ, Dembri A, Durrer C, Duchene D. Mucoadhesion of colloidal particulate systems in the gastro-intestinal tract. Eur. J. Pharm. Biopharm. 44(1), 25-31 (1997